胰十二指肠切除术后出血部位及减轻策略
这项回顾性队列研究分析了2011至2021年两家中心3040例胰十二指肠切除术患者,发现术后需侵入性干预的出血发生率为3.0%,胃十二指肠动脉仅为少数出血来源(占所有出血事件的16.2%),经验性胃十二指肠动脉栓塞或支架置入与显著并发症和再出血相关,不应作为常规实践。
要点
- 原发性出血90例(3.0%),其中胃十二指肠动脉来源15例(16.7%),不明部位24例(26.7%),非胃十二指肠动脉部位51例(56.7%)。
- 胃十二指肠动脉出血更常与软腺体质地相关(14例[93.3%] vs 41例[62.1%],P=.02),且出现时间更晚(中位21天 vs 10天,P=.002)。
- 经验性胃十二指肠动脉栓塞或支架置入后30.4%(7/23)发生继发性出血,全部胃十二指肠动脉栓塞/支架置入中20%(8/40)出现显著并发症。
核心结论
- 胰十二指肠切除术后出血不常见且谱系广泛,胃十二指肠动脉仅占出血事件的少数。
- 无近期出血明显后遗症时行经验性胃十二指肠动脉栓塞/支架置入与显著并发症和再出血相关,不应作为常规实践。
- 成功治疗胰十二指肠切除术后出血需要仔细评估所有潜在来源,即使在胃十二指肠动脉已行减轻策略后。
研究设计与样本
- 回顾性队列研究,纳入2011至2021年在纪念斯隆凯特琳癌症中心(MSK)和托马斯杰斐逊大学医院(TJUH)连续接受胰十二指肠切除术的患者,共3040例(MSK 1761例,TJUH 1279例)。
- 暴露因素为人口学、围术期和疾病相关变量。
- 主要结局为需侵入性干预的原发性(初始)和继发性(复发性)出血的发生率、部位、治疗和结局;影像学由介入放射科医生重新审阅以确认部位。
主要发现
- 原发性出血发生于90例(3.0%),其中胃十二指肠动脉来源15例(16.7%),不明部位24例(26.7%),非胃十二指肠动脉部位51例(56.7%)。
- 继发性出血发生于23例,其中4例(17.4%)胃十二指肠动脉为来源;所有出血事件(n=117)中胃十二指肠动脉来源19例(16.2%,占所有胰十二指肠切除术的0.63%)。
- 胃十二指肠动脉出血更常与软腺体质地相关(14例[93.3%] vs 41例[62.1%],P=.02),且出现时间更晚(中位[IQR] 21[15-26]天 vs 10天[5-18],P=.002)。
- 23例接受经验性胃十二指肠动脉栓塞或支架置入,其中7例(30.4%)随后发生继发性出血。
- 全部胃十二指肠动脉栓塞/支架置入中20%(8/40例),包括经验性治疗的13%(3/13例),与显著并发症相关(7例肝梗死,4例胆道狭窄),这些并发症患者的90天死亡率为38.5%(n=5) vs 无并发症者7.8%(n=6;P=.008)。
临床怎么用
- 作者认为,无近期出血明显后遗症时经验性胃十二指肠动脉栓塞/支架置入不应作为常规实践。
- 作者指出,成功治疗胰十二指肠切除术后出血需要仔细评估所有潜在来源,即使在胃十二指肠动脉已行减轻策略后。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Postpancreatectomy hemorrhage is an uncommon but highly morbid complication of pancreaticoduodenectomy. Clinical evidence often draws suspicion to the gastroduodenal artery stump, even without a clear source. OBJECTIVE: To determine the frequency of gastroduodenal artery bleeding compared to other sites and the results of mitigation strategies. DESIGN, SETTING, AND PARTICIPANTS: This cohort study involved a retrospective analysis of data for consecutive patients who had pancreaticoduodenectomy from 2011 to 2021 at Memorial Sloan Kettering Cancer Center (MSK) and Thomas Jefferson University Hospital (TJUH). EXPOSURES: Demographic, perioperative, and disease-related variables. MAIN OUTCOMES AND MEASURES: The incidence, location, treatment, and outcomes of primary (initial) and secondary (recurrent) hemorrhage requiring invasive intervention were analyzed. Imaging studies were re-reviewed by interventional radiologists to confirm sites. RESULTS: Inclusion criteria were met by 3040 patients (n = 1761 MSK, n = 1279 TJUH). Patients from both institutions were similar in age (median [IQR] age at MSK, 67 [59-74] years, and at TJUH, 68 [60-75] years) and sex (at MSK, 814 female [46.5%] and 947 male [53.8%], and at TJUH, 623 [48.7%] and 623 male [51.3%]). Primary hemorrhage occurred in 90 patients (3.0%), of which the gastroduodenal artery was the source in 15 (16.7%), unidentified sites in 24 (26.7%), and non-gastroduodenal artery sites in 51 (56.7%). Secondary hemorrhage occurred in 23 patients; in 4 (17.4%), the gastroduodenal artery was the source. Of all hemorrhage events (n = 117), the gastroduodenal artery was the source in 19 (16.2%, 0.63% incidence in all pancreaticoduodenectomies). Gastroduodenal artery hemorrhage was more often associated with soft gland texture (14 [93.3%] vs 41 [62.1%]; P = .02) and later presentation (median [IQR], 21 [15-26] vs 10 days [5-18]; P = .002). Twenty-three patients underwent empirical gastroduodenal artery embolization or stent placement, 7 (30.4%) of whom subsequently experienced secondary hemorrhage. Twenty percent of all gastroduodenal artery embolizations/stents (8/40 patients), including 13% (3/13 patients) of empirical treatments, were associated with significant morbidity (7 hepatic infarction, 4 biliary stricture), with a 90-day mortality rate of 38.5% (n = 5) for patients with these complications vs 7.8% without (n = 6; P = .008). Ninety-day mortality was 12.2% (n = 11) for patients with hemorrhage (3 patients [20%] with primary gastroduodenal vs 8 [10.7%] for all others; P = .38) compared with 2% (n = 59) for patients without hemorrhage. CONCLUSIONS AND RELEVANCE: In this study, postpancreatectomy hemorrhage was uncommon and the spectrum was broad, with the gastroduodenal artery responsible for a minority of bleeding events. Empirical gastroduodenal artery embolization/stent without obvious sequelae of recent hemorrhage was associated with significant morbidity and rebleeding and should not be routine practice. Successful treatment of postpancreatectomy hemorrhage requires careful assessment of all potential sources, even after gastroduodenal artery mitigation.
引用
- Preston WA, Collins ML, Gönen M, et al. Hemorrhage Sites and Mitigation Strategies After Pancreaticoduodenectomy. JAMA Surg. 2024. PMID: 38776076. doi:10.1001/jamasurg.2024.1228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。